Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jürg H Beer

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Praxis|September 14, 2011
["Xa-tra-xa": opportunities and open questions about new anticoagulants]Jürg H Beer
Current Hematology Reports|April 17, 2004
Aspirin resistance for cliniciansJürg H Beer
Swiss Medical Weekly|January 10, 2013
Vitamin K antagonists are hard to beat by the price - are they? Some answers, new questions and the GPs dilemmaJürg H Beer
British Journal of Haematology|February 18, 2017
Antibiotic use associated with VTE and its implications: a new trigger for thromboprophylaxis and for reclassification of some unprovoked to provoked VTE's?Jürg H Beer
Therapeutische Umschau. Revue Therapeutique|January 4, 2017
Jürg H Beer
Swiss Medical Weekly|January 16, 2015
Investigators of studies of n = 1: pioneers or kamikazes?N Bonetti, Jürg H Beer
Therapeutische Umschau. Revue Therapeutique|January 4, 2017
Nicole Bonetti, Jürg H Beer
European Heart Journal|December 26, 2025
(Dis)solving the inflammatory neutrophil extracellular traps of venous thromboembolism with P2Y14 antagonistsJürg H Beer, Carolina Balbi
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in the management of venous thromboembolism--evidence from major clinical trialsErik W Holy, Jürg H Beer
Journal of Molecular and Cellular Cardiology|June 21, 2020
Apelin-potential therapy for COVID-19?Seyed Soheil Saeedi Saravi, Jürg H Beer
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Praxis|September 14, 2011
["Xa-tra-xa": opportunities and open questions about new anticoagulants]Jürg H Beer
Current Hematology Reports|April 17, 2004
Aspirin resistance for cliniciansJürg H Beer
Swiss Medical Weekly|January 10, 2013
Vitamin K antagonists are hard to beat by the price - are they? Some answers, new questions and the GPs dilemmaJürg H Beer
British Journal of Haematology|February 18, 2017
Antibiotic use associated with VTE and its implications: a new trigger for thromboprophylaxis and for reclassification of some unprovoked to provoked VTE's?Jürg H Beer
Therapeutische Umschau. Revue Therapeutique|January 4, 2017
Jürg H Beer
Swiss Medical Weekly|January 16, 2015
Investigators of studies of n = 1: pioneers or kamikazes?N Bonetti, Jürg H Beer
Therapeutische Umschau. Revue Therapeutique|January 4, 2017
Nicole Bonetti, Jürg H Beer
European Heart Journal|December 26, 2025
(Dis)solving the inflammatory neutrophil extracellular traps of venous thromboembolism with P2Y14 antagonistsJürg H Beer, Carolina Balbi
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in the management of venous thromboembolism--evidence from major clinical trialsErik W Holy, Jürg H Beer
Journal of Molecular and Cellular Cardiology|June 21, 2020
Apelin-potential therapy for COVID-19?Seyed Soheil Saeedi Saravi, Jürg H Beer
Pageof 12